State Of Wyoming Magenta Therapeutics, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.97 - $3.08 $1,496 - $4,752	-1,543 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.55 - $5.23 $102 - $209	40 Added 2.66%	1,543 $4,000
Q4 2021 Feb 11, 2022	BUY	$4.43 - $8.33 $310 - $583	70 Added 4.88%	1,503 $7,000
Q3 2021 Feb 11, 2022	BUY	$6.07 - $9.89 $1,651 - $2,690	272 Added 23.43%	1,433 $10,000
Q2 2021 Feb 11, 2022	BUY	$9.76 - $14.15 $11,331 - $16,428	1,161 New	1,161 $11,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.